Spm 927 for add-on therapy of schizophrenia

Details Spm 927 for add-on therapy of schizophrenia Spm 927 for add-on therapy of schizophrenia

A - Human Necessities

61

K

A61K 31/165 (2006.01) A61P 25/18 (2006.01)

Patent

CA 2595330

The present invention is directed to the use of a class of peptide compounds for the prevention, alleviation or/and treatment of a disease that is treated with antipsychotics, in particular psychosis, more particular schizophrenia, in an add-on therapy to at least one antipsychotic.

La présente invention concerne l'utilisation d'une classe de composés peptidiques pour la prévention, le soulagement et/ou le traitement d'une maladie qui est traitée à l'aide d'antipsychotiques, en particulier la psychose, plus particulièrement la schizophrénie, dans un traitement d'appoint d'au moins un antipsychotique.

Affiliated with

Also associated with

Rating

Spm 927 for add-on therapy of schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spm 927 for add-on therapy of schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spm 927 for add-on therapy of schizophrenia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1523626